Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Jay D. Miller Appointed Chief Executive Officer
, July 29, 2013
/PRNewswire/ - IMRIS Inc. (NASDAQ:
IMRS; TSX: IM) ("IMRIS" or the "Company") today announced that Jay D.
, the company's current President and COO, will also become the
CEO of IMRIS Inc., effective August 1, 2013.
Chairman and CEO David
will continue as the Chair of the Board of Directors of the
"IMRIS has grown from a single idea into a business that impacts the
lives of patients every day," said David Graves. "Our company has sold
systems all over the world and is well positioned to enter into this
next stage of growth under Jay's leadership. Since our inception we
have successfully commercialized intraoperative surgery systems based
on MR and now we have completed the intraoperative CT, which has the
ability to put another strong revenue stream into the company. We have
built a global sales capacity and customer base and have navigated some
of the most challenging economic conditions in recent times. We are on
track for the completion of the Symbis® Surgical System, our MR-compatible Surgical Robot, and our MR-guided
Radiation Therapy platform. We have a compelling line up of
in-the-market and development stage products that will provide a strong
foundation for the company as it goes forward. The goal of all IMRIS
products is to improve patient outcomes and reduce the cost of care in
the treatment of disease."
"The innovation and technology foundation at IMRIS was instrumental in
my decision to join the company," said Jay Miller. "IMRIS is infused
with a culture of excellence and a proven ability to commercialize
technology. It is my goal to drive the adoption of products and
services by customers and to provide great returns for investors. This
is an exciting opportunity to lead the next phase in the growth of a
world class medical device company."
Miller joined IMRIS in September 2012 as President and COO. Miller
previously was the CEO of Zonare Inc., and CEO of Vital Images. Prior
to that he held senior positions with GE Healthcare after starting his
career with Siemens Medical Systems. He has a BA from Dartmouth, an
MSc in Biomedical Engineering from University of Virginia and an MBA
IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image
guided therapy solutions through its VISIUS® Surgical Theatre - a revolutionary, multifunctional surgical
environment that provides unmatched intraoperative vision to clinicians
to assist in decision making and enhance precision in treatment. VISIUS® Surgical Theatres serve the neurosurgical, spine, cardiovascular and
SOURCE IMRIS Inc.